These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9349473)

  • 1. No reactivation of attenuated immunodeficiency viruses in rhesus macaques after vaccinia virus-induced immune activation.
    Dittmer U; Nisslein T; Meyerhans A; Hunsmann G; Stahl-Hennig C
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2523-8. PubMed ID: 9349473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma.
    Stahl-Hennig C; Gundlach BR; Dittmer U; ten Haaft P; Heeney J; Zou W; Emilie D; Sopper S; Uberla K
    Virology; 2003 Jan; 305(2):473-85. PubMed ID: 12573592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.
    Khatissian E; Monceaux V; Cumont MC; Kieny MP; Aubertin AM; Hurtrel B
    J Virol; 2001 Feb; 75(3):1507-15. PubMed ID: 11152522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.
    Titti F; Sernicola L; Geraci A; Panzini G; Di Fabio S; Belli R; Monardo F; Borsetti A; Maggiorella MT; Koanga-Mogtomo M; Corrias F; Zamarchi R; Amadori A; Chieco-Bianchi L; Verani P
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2529-39. PubMed ID: 9349474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion.
    Stahl-Hennig C; Dittmer U; Nisslein T; Pekrun K; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Rud EW; Hunsmann G
    Immunol Lett; 1996 Jun; 51(1-2):129-35. PubMed ID: 8811357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose.
    Cranage MP; Sharpe SA; Whatmore AM; Polyanskaya N; Norley S; Cook N; Leech S; Dennis MJ; Hall GA
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1935-44. PubMed ID: 9714241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.
    Sawai ET; Hamza MS; Ye M; Shaw KE; Luciw PA
    J Virol; 2000 Feb; 74(4):2038-45. PubMed ID: 10644378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.
    Gundlach BR; Lewis MG; Sopper S; Schnell T; Sodroski J; Stahl-Hennig C; Uberla K
    J Virol; 2000 Apr; 74(8):3537-42. PubMed ID: 10729127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
    Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
    Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
    Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
    Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.
    Cranage MP; Whatmore AM; Sharpe SA; Cook N; Polyanskaya N; Leech S; Smith JD; Rud EW; Dennis MJ; Hall GA
    Virology; 1997 Mar; 229(1):143-54. PubMed ID: 9123856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy.
    Uberla K; Rosenwirth B; Ten Haaft P; Heeney J; Sutter G; Erfle V
    J Med Primatol; 2007 Feb; 36(1):2-9. PubMed ID: 17359459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
    Bogers WM; Niphuis H; ten Haaft P; Laman JD; Koornstra W; Heeney JL
    AIDS; 1995 Dec; 9(12):F13-8. PubMed ID: 8605046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
    Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
    Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
    Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.